{"id":"W3083807864","doi":"10.1016/j.jchf.2020.06.015","title":"Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause","year":2020,"lang":"en","type":"article","venue":"JACC Heart Failure","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; Sanofi Pasteur; Baxter Healthcare Corporation; National Institutes of Health; DalCor Pharmaceuticals; Novo Nordisk; GlaxoSmithKline; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Bayer Fund; Actavis; Boston Scientific Corporation; British Heart Foundation; Cytokinetics; AbbVie; Bayer; Gilead Sciences; AstraZeneca; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Novartis; Merck; Akebia Therapeutics; Bristol-Myers Squibb; Pfizer; Boehringer Ingelheim; Amgen; Abbott Laboratories; Kidney Research UK; Medtronic","keywords":"Medicine; Implantable cardioverter-defibrillator; Hazard ratio; Internal medicine; Valsartan; Sacubitril, Valsartan; Heart failure; Cardiology; Ejection fraction; Sudden cardiac death; Sacubitril; Cardiomyopathy; Confidence interval; Blood pressure","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002396233,0.0004285339,0.002101044,0.0001632245,0.0003409123,0.0002934485,0.00002547271,0.0002104803,0.000004573523],"category_scores_gemma":[0.0003998625,0.0003910075,0.0003127963,0.0004401402,0.00006241948,0.0003819468,0.0002513957,0.0002864331,0.00009859468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006390909,"about_ca_system_score_gemma":0.0001040548,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003893926,"about_ca_topic_score_gemma":0.00002916031,"domain_scores_codex":[0.997578,0.0001189704,0.0004072822,0.0008036011,0.0004826556,0.0006095318],"domain_scores_gemma":[0.998082,0.0003196493,0.0000611697,0.0004432094,0.0001958999,0.0008981096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001186678,0.000005173365,0.5533043,0.0001153264,0.0003484379,0.000004719539,0.0007142199,0.00001378808,0.01809291,0.00003876554,0.4271536,0.00009003425],"study_design_scores_gemma":[0.000911637,0.0002278068,0.09819937,0.0001532383,0.0004240014,0.001109649,0.002082017,0.00001316405,0.002086794,0.00000623891,0.8943362,0.0004499261],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868961,0.002195755,0.00006341501,0.006657239,0.0002151842,0.0008230857,0.0002549498,0.0002725257,0.002621728],"genre_scores_gemma":[0.9918332,0.0001401769,0.00359626,0.003221492,0.0009604563,0.00002207167,0.00002523592,0.00007380304,0.0001273533],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4671825,"threshold_uncertainty_score":0.9998542,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04087361945055903,"score_gpt":0.2864771530589053,"score_spread":0.2456035336083463,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}